A nxiety is 'an unpleasant emotional state ranging from mild unease to intense fear' (British Medical Association (BMA), 2002) . Although anxiety is a normal response to stressful situations it can be seen as a chronic manifestation of a modern lifestyle that includes repeated daily stressors (Pavlovich, 1999) . It is a potentially serious disorder as it can precipitate a number of health problems and diffi culties in social and occupational functioning (Fricchione, 2004) .
Physical symptoms of anxiety include pallor, sweating, hyperventilation, diarrhoea, irritable bowel, fl ushing, dysphagia, palpitations, nausea, and muscle tension (BMA, 2002) . Furthermore, Pitsavos et al (2006) found strong evidence for a positive association between severity of state anxiety in both men and women and increased levels of plasma pro-infl ammatory cytokines, coagulation factors, C-reactive protein and white blood cells. Alleviation of these adverse eff ects on health is important.
Many orthodox anxiolytic treatments can have unwanted side eff ects. Benzodiazepines, for example, have been linked to muscle weakness, amnesia, headaches, vertigo, urinary retention, slurred speech and gastrointestinal disturbances. They may lead to tolerance and physical and psychological dependence, and are considered to be dangerous to use long-term (BNF, 2008) . The side eff ects of antipsychotics, sometimes prescribed in the short-term for severe anxiety, include tremor, abnormal face and body movements and restlessness (BNF, 2008) . Beta-blockers may be prescribed for relief of physical symptoms, such as tremors and palpitations, associated with anxiety. However, side eff ects are similar to those of benzodiadepines and may additionally include bradycardia, vasoconstriction and heart failure (BNF, 2008) . There is therefore a need for safe alternatives, without unwanted side eff ects.
American skullcap (Scutellaria laterifl ora) ( Figure  1) is one of the most commonly used herbs by western medical herbalists, particularly for anxiety and related conditions (Bergner, 2002 (Bergner, -2003 . This article discusses its clinical application, and reviews both scientifi c and anecdotal evidence in support of its traditional use for anxiety.
American skullcap (Scutellaria laterifl ora L)
Scutellaria laterifl ora is a perennial herb belonging to the Lamiaceae (mint) family and is one of 360 known skullcap species worldwide (Malikov and Yuldashev, 2002) . It grows on wetlands and is indigenous to North America and Canada where it is widely distributed (USDA). It also grows on riverbanks and marshes in northern Iran (Yaghmai, 1988) and is grown commercially worldwide (Wills and Stuart, 2004) .
It was an important North American ethnobotanical medicine for use in anxiety, hysteria, phobias, panic attacks, tension, sleep disorders and stress (Felter and Lloyd, 1898; Joshee et al, 2002) . It has also been used for centuries in both Persian and Cherokee folk medicine for nervous disorders of the American skullcap (Scutellaria laterifl ora): an ancient remedy for today's anxiety? digestive tract (Khosh, 2000) and Native American women traditionally used it for premenstrual tension (Indiana Medical History Museum, undated). The herb is also used extensively and highly valued in traditional western herbal medicine. It was mentioned in the fi rst American materia medica in 1785 but had been in longstanding use as a home remedy before then (Lloyd 1911; 109) .
In modern western herbal medicine it is used most commonly for insomnia, nervous disorders and digestive disturbances (Greenfi eld and Davis 2004) . Bergner (2002 Bergner ( -2003 proposes its action is primarily as a trophorestorative on the central nervous system, allowing relaxation following nervous exhaustion. It is also used for barbiturate and tranquilliser withdrawal symptoms (Joshee et al, 2002) , fi bromyalgia, anorexia nervosa, post-stroke paralysis, atherosclerosis, hyperlipidaemia, allergies, skin conditions, and infl ammation (Natural Medicines Comprehensive Database, 2008) .
Following reports of liver damage from use of S. laterifl ora products there was a decline in its popularity in the 1970s and 1980s (McCaleb, 2004) . The cause of the hepatotoxicity was probably due to contamination with Germander (Teucrium) species (De Smet, 1999) , which contains pyrrolizidine alkaloids (McCaleb, 2004) . S. laterifl ora is not associated with hepatotoxicity.
Since 2002 there has been a sharp increase in demand for S. laterifl ora, possibly due to it being favoured as an anxiolytic alternative to the previously popular Piper methysticum (kava kava), which, due to toxicity fears, is no longer widely prescribed by herbalists in Europe (Greenfi eld and Davis, 2004) .
Scutellaria baicalensis (Georgi) (Baikal skullcap) root is extensively prescribed in traditional Chinese and Japanese (kampo) medicines. In particular, this is used to treat infl ammatory diseases, and has been widely researched in relation to its effi cacy and pharmacological properties. Although S. laterifl ora is a popular herb in western herbal medicine and is contained in many herbal formulations (Joshee et al, 2002) , particularly for anxiety and stress, relatively few scientifi c studies of this herb exist (Cole et al, 2008) .
S. laterifl ora is the practitioner's choice for treating anxiety
Results of a survey conducted by the authors among herbal medicine practitioners in the UK and Ireland indicate that S. laterifl ora is considered to be an eff ective intervention for anxiety and stress and is commonly prescribed for these conditions and related co-morbidities.
The survey aimed to gather information on the extent of, and indications for, current use of S. laterifl ora. It also looked at perceptions of its eff ectiveness and safety. Herbal medicine practitioners were selected from the membership list of the National Institute of Medical Herbalists (NIMH). All members with identifi able email addresses were contacted (n = 377) and responses were received from 62 (a 16% response rate).
Results indicate primary use of S. laterifl ora for relief of anxiety, stress or associated symptoms. More than eight respondents in ten (84%) said they would prescribe it for specifi c anxiety disorders and 100% for anxiety-related co-morbidities. Twenty fi ve respondents said it is their preferred herb for anxiety ( Figure 2) . One respondent said his or her preferred anxiolytic was S. baicalensis. In common with many other Scutellaria species, Plant life: Scutellaria laterifl ora L.
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S. laterifl ora and S. baicalensis have similar phytochemical constituents, although in diff erent ratios and quantities. This may explain the diff ering traditional uses among Scutellaria species. For instance, S. baicalensis contains 800 times more scutellarin than S. laterifl ora (Cole et al, 2008) . Although S. baicalensis is most commonly used for infl ammation (Joshee et al, 2002) both S. laterifl ora and S. baicalensis have been found to inhibit cyclooexgenases in vitro (Gafner et al, 2004; Jia et al, 2007) . S. laterifl ora is reported to have been traditionally used for infl ammation. The Iroquai tribe, for example, used it 'to keep the throat clear' (Joshee et al, 2002) . Conversely, S. balicalensis root is reported to have been used as a sedative (Liao et al, 1998) .
All respondents who regularly prescribe S. laterifl ora (92%) said they did so for anxiety. Some reported it useful in depression (16%), while several respondents said it was unsuitable for signifi cant depression.
Use for insomnia and sleep-related disorders was specifi cally reported by 57% of respondents. Other conditions for which it was used include fear and panic states, migraine and other headaches, muscular tension, physical and mental exhaustion and post viral fatigue. Three practitioners also said it was useful in emotional disturbance in menopause and in cases of premenstrual syndrome.
The survey respondents reported the herb as being used over a range of time periods from immediate short-term use to several years. They said a positive response was expected by patients within the fi rst two weeks of use and that this persists throughout the period of use.
The most common benefi ts reported by patients to their practitioners were feeling calmer, improved sleep patterns and quality of sleep, and better able to cope in stressful situations. Other positive eff ects were mood elevation, increased energy, being more focused and feeling generally more relaxed.
Tinctures made from either fresh or dried organic and non-organic herb are the preferred mode of administration by respondents. The main reason is a belief that tinctures are more eff ective, are better for patient compliance and are generally more convenient than dried herbs. Many (63%) said they prefered using organic S. laterifl ora, while 42% preferred tinctures made from the fresh herb, believing this to be the most eff ective.
All respondents prescribe the herb in combination with other herbs. Only 9% of the respondents regularly prescribed S. laterifl ora as a single herb so it is diffi cult to draw conclusions about the perceived actions of S. laterifl ora used in isolation. Nevertheless the practitioners appeared confi dent about attributing specifi c actions and responses to S. laterifl ora as distinct from other herbs in a mixture in having the anxiolytic actions. Furthermore, respondents prescribing it as a single herb reported positive feedback from their patients.
Examples include reduced anxiety, fewer and less intense panic attacks, feeling of wellbeing, feeling more positive, and more able to cope. Interestingly, one practitioner prescribing the herb in combination reported a relapse in symptoms of anxiety in some patients whenever it was removed from the mix.
The herb was reported as being well tolerated with no reports of toxicity and only minor and infrequent side eff ects (reported by seven users). These included daytime drowsiness, mild digestive upset and vivid dreaming. It is uncertain whether any of these side eff ects were in fact due to S. laterifl ora.
It is recognised that the response rate (16%) was low and that all the survey respondents replied to email contact and therefore may not be representative of herbal practitioners in general in the UK and Ireland. The poor response rate and the propensity of respondents to administer S. laterifl ora in combination with other herbs make it impossible to rely on evidence regarding the effi cacy of the herb from the practitioner 
Preparations and dosages used
Contraindications and sideeffects
Due to its potential sedative action (Greenfi eld and Davis, 2004) , it may be advisable to refrain from using S. laterifl ora in combination with other sedatives, such as alcohol and benzodiazepines. It is not possible to comment on the safety of its use in pregnancy.
Anxiety: the demand for herbal treatment
In one year up to one adult in six in the UK suff ers from a medically unexplained psychological disorder. The most common are anxiety (men 4%; women 5%), depression (men 2%; women 3%) or both experienced at the same time (men 7%; women 11%). These fi gures indicate that anxiety and depression are more prevalent in women than in men (Offi ce for National Statistics, 2006) . Herbal medicine is used more frequently by women than by men (Gunther et al, 2004) and, according to a survey in the United States (del Mundo et al, 2002) around 30% of visits to a complementary and alternative medicine (CAM) practitioner were for anxiety and/or stress. Of 664 respondents (74% of whom were females), only back pain was a more common reason for CAM visits. As chiropractors were the most visited CAM therapists, with medical herbalists a close second, it may be deduced that since the chiropractors are more likely to treat back pain, the majority of visits to herbal medicine practitioners were by women with anxiety and stress (del Mundo et al, 2002).
The potential effi cacy of S. laterifl ora in treating anxiety
Chemistry S. laterifl ora is rich in fl avonoids, a group of phenolic compounds that are highly active physiologically, and have been attributed with its anxiolytic eff ects. Baicalin, its aglycone baicalein, wogonin and laterifl orin are the major fl avonoids in S. laterifl ora (Nishikawa et al, 1999; Gafner et al, 2000; Gafner et al, 2004) . It also contains γ-aminobutyric acid (GABA), an inhibitory neurotransmitter that modulates anxiety, sleep, convulsions and mood (Rabow et al, 1995) , and markedly high levels of glutamine, a nonessential amino acid that plays an important role in immune function-particularly in response to stress (Bergeron et al, 2005) . Although GABA does not readily cross the blood-brain barrier (Spinella, 2002) , glutamine can and may be biosynthesised to GABA by GABA-ergic neurons. The presence of glutamine in the herb may therefore contribute to its anxiolytic activity by increasing the availability of GABA in the central nervous system (Bergeron et al, 2005) .
In vitro studies
Benzodiazepines are allosteric ligands for the GABA A receptor, a chloride channel that is gated by GABA. They bind to the benzodiazepine site of the GABA A receptor, thus increasing the affi nity of the inhibitory neurotransmitter GABA for the GABA site of the GABA A receptor. This decreases the likelihood of action potentials by excitatory neurotransmitters (Rabow et al, 1995) . One important study (Liao et al, 1998) indicated oroxylin A, baicalein and wogonin, which are fl avonoids found in S. laterifl ora, had weak affi nities for the benzodiazepine site of GABA A receptors in mouse cerebral cortex in vitro. In another study Hui et al (2000) tested the capacity of baicalin, baicalein, scutellarein and wogonin to bind to the benzodiazepine site of the GABA A receptor in homogenised rat brain. Affi nity to the benzodiazepine site for scutellarein was moderate and weak for baicalin. Contrary to results of the earlier study (Liao et al, 1998) , the binding affi nities of wogonin and baicalein were strong. The authors suggested the discrepancy may be due to diff erences in species and assay models used (Hui et al, 2000) .
The ability of the skullcap fl avonoids to bind to the benzodiazepine site of the GABA A receptor suggests an anxiolytic eff ect for S. laterifl ora but studies on human tissue of neuronal origin are needed to verify results.
Gafner et al (2003) found extracts of dried S.
laterifl ora aerial parts and its fl avonoids baicalin, scutellarin, wogonin, laterifl orein, ikonnikoside I and dihydrobaicalin, had high affi nity for the serotonin7 (5-HT7) receptor in human 5-HT7 -transfected Chinese hamster ovary cell lines. It was not known whether these extracts and fl avonoids were agonists or antagonists (Gafner et al, 2003) , but 5-HT7 receptor antagonists and inverse agonists are known to be useful in the treatment of premenstrual syndrome, sleep disorders, appetite disorders, anxiety, phobias, panic, and stress-related disorders (Bright et al, 2004) ; these are also conditions for which S. laterifl ora is traditionally used (Joshee et al, 2002; Greenfi eld and Davis, 2004) .
Human clinical trials
To date only one clinical trial has been published on S. laterifl ora. Wolfson and Hoff mann (2003) assessed its short-term anxiolytic properties in a double-blind, placebo-controlled crossover study of 19 healthy volunteers. Participants took either two placebo capsules, one capsule containing 100 mg of organic freeze-dried S. laterifl ora, two capsules of these, or one capsule of 350 mg organic freeze-dried S. laterifl ora. Participants' energy, cognition and anxiety were self-rated at various time points up to two hours following administration. All three herb tests had notable eff ects on subjective anxiety scores when compared to placebo. There was only a very mild decline in cognition and energy with the herbs, with no adverse reactions or side-eff ects, suggesting that S. laterifl ora could be a valuable anxiolytic (Wolfson and Hoff mann, 2003) . More research needs to be conducted in order to assess long-term eff ects. Furthermore, the authors acknowledge that the use of validated psychometric tests is needed to determine the herb's clinical anxiolytic eff ects.
Summary and evaluation of experimental results
The receptor binding affi nities of fl avonoids present in S. laterifl ora, including baicalein, baicalin, wogonin and scutellarein, to GABA A -BDZ receptor sites in vitro (Liao et al, 1998; Hui et al, 2000) indicates a possible anxiolytic action for the herb as does the presence of glutamine and the ability of certain S. laterifl ora fl avonoids to bind to 5HT7 receptors in vitro (Gafner et al, 2003) . The results of a survey among herbal medicine practitioners on their use of the herb and of a clinical study lend further support to its eff ectiveness as an anxiolytic.
The majority of in vitro fi ndings are as a result of research conducted using individual phytochemicals of S. laterifl ora. While orthodox medicine tends to employ isolated phytochemicals, herbal medicine uses whole plant parts in the belief that there are synergistic benefi ts of the multiple active constituents in a single herb (Spinella 2002) . It is likely that the effi cacy of S. laterifl ora is due to its multiple constituents acting in synergy rather than to the summative activities of the constituent phytochemicals. There is still a need for more research into the pharmacology of extracts from whole aerial parts of the herb and the variability which may arise from the herb sourced from diff erent geographical regions.
Conclusions
The traditional therapeutic uses of S. laterifl ora are supported by evidence from research. A positive therapeutic benefi t of the herb for anxiety is indicated by the results of a survey conducted among herbal medicine practitioners; in vitro and chemical studies; and a clinical trial, which supports its reputation for safety as well as its effi cacy as an anxiolytic.
As with all studies of herbal medicines important considerations, which may impact on fi ndings, are the variations in quality and quantity of any given herbal preparation as well as the eff ects of other herbs in a mixture. Commercial herbal products have been found to contain signifi cant variations in phytochemical profi le within a species. Such variation may be according to geographic region, biodiversity, ecological variations, cultivation, seasonality, harvesting, processing method, and marc to menstrum ratio. Alcohol concentration, and storage time aff ecting stability are other factors (Ciddi, 2006; Gao et al, 2008) . Stability of a herbal product is important with regard to effi cacy and safety and may be aff ected by various factors, such as pH, light, enzymatic degradation (for example due to harvesting stress, heat or insects) and temperature (Gafner and Bergeron 2005) .
Furthermore, quality control of S. laterifl ora is important to not only ensure high standards of effi cacy but also for reasons of safety. It is frequently adulterated with germander species or other skullcap species, both deliberately (germander has a heavier dry weight) and due to misidentifi cation of the large number of skullcap species (Gorman, 2008) . High Performance Liquid Chromatography (HPLC) methods can be used to verify its purity and quality. A characteristic profi le of the HPLC chromatogram or 'fi ngerprint' , which is altered by adulteration, can be used for accurate identifi cation of the herb. The pattern's relative
